- ANTX Dashboard
- Financials
- Filings
-
Holdings
-
Transcripts
- ETFs
- Insider
-
Institutional
- Shorts
AN2 Therapeutics (ANTX) Institutional ownership
Company Profile
Type | Filer | #Shares | Filed | For date | #Previous | %Chg | Prev. Date |
---|---|---|---|---|---|---|---|
SC 13G/A
|
RA Capital Management, L.P | 0.00 | 14 Feb 25 | 31 Dec 24 | 2.00 mm | -100% | 30 Sep 24 |
SC 13G/A
|
TCG Crossover GP I | 0.00 | 14 Feb 25 | 31 Dec 24 | 1.56 mm | -100% | 30 Sep 24 |
13F-HR
|
Schonfeld Strategic Advisors | 26.90 k | 14 Feb 25 | 31 Dec 24 | 66.10 k | -59% | 30 Sep 24 |
SC 13G/A
|
Brii Biosciences Limited | 927.20 k | 14 Feb 25 | 31 Dec 24 | 1.05 mm | -12% | 31 Dec 22 |
13F-HR
|
Morgan Stanley | 300.00 | 14 Feb 25 | 31 Dec 24 | 3.00 | 30 Sep 24 | |
13F-HR
|
Millennium Management | 209.37 k | 14 Feb 25 | 31 Dec 24 | 397.93 k | -47% | 30 Sep 24 |
13F-HR
|
Citadel Advisors | 67.99 k | 14 Feb 25 | 31 Dec 24 | 0.00 | +∞% | 30 Sep 24 |
13F-HR/A
|
Morgan Stanley | 3.00 | 14 Feb 25 | 30 Sep 24 | 3.00 | 0% | 31 Mar 24 |
13F-HR
|
Northern Trust | 43.20 k | 14 Feb 25 | 31 Dec 24 | 32.60 k | +33% | 30 Sep 24 |
13F-HR
|
Almitas Capital | 1.31 mm | 14 Feb 25 | 31 Dec 24 | 0.00 | +∞% | 30 Sep 24 |
This data is updated daily from 13F, 13D and 13G SEC filings.
Faded values represent incomplete data for the quarter, where values have been used from the previous quarter for institutions that haven't filed updated data yet.
We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.